Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recognizing Endocrinopathies Associated With Tyrosine Kinase Inhibitor Therapy in Children With Chronic Myelogenous Leukemia
Jill Samis, Paul Lee, Donald Zimmerman, et al.
Pediatric Blood & Cancer (2016) Vol. 63, Iss. 8, pp. 1332-1338
Closed Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Hypothalamic–Pituitary and Growth Disorders in Survivors of Childhood Cancer: An Endocrine Society* Clinical Practice Guideline
Charles A. Sklar, Zoltan Antal, Wassim Chemaitilly, et al.
The Journal of Clinical Endocrinology & Metabolism (2018) Vol. 103, Iss. 8, pp. 2761-2784
Open Access | Times Cited: 179
Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement
Margaret Cristina da Silva Boguszewski, César Luiz Boguszewski, Wassim Chemaitilly, et al.
European Journal of Endocrinology (2022) Vol. 186, Iss. 6, pp. P35-P52
Open Access | Times Cited: 70
How I treat chronic myeloid leukemia in children and adolescents
Nobuko Hijiya, Meinolf Suttorp
Blood (2019) Vol. 133, Iss. 22, pp. 2374-2384
Open Access | Times Cited: 113
Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial
Meinolf Suttorp, Philipp Schulze, Ingmar Glauche, et al.
Leukemia (2018) Vol. 32, Iss. 7, pp. 1657-1669
Closed Access | Times Cited: 105
NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017
Arnel Pallera, Jessica K. Altman, Ellin Berman, et al.
Journal of the National Comprehensive Cancer Network (2016) Vol. 14, Iss. 12, pp. 1505-1512
Open Access | Times Cited: 84
Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group
Uma H. Athale, Nobuko Hijiya, Briana C. Patterson, et al.
Pediatric Blood & Cancer (2019) Vol. 66, Iss. 9
Open Access | Times Cited: 70
Factors influencing risk‐based care of the childhood cancer survivor in the 21st century
Stephanie B. Dixon, Kari Bjornard, Nicole M. Alberts, et al.
CA A Cancer Journal for Clinicians (2018) Vol. 68, Iss. 2, pp. 133-152
Open Access | Times Cited: 66
Pharmacology and pharmacokinetics of imatinib in pediatric patients
Meinolf Suttorp, Martin Bornhäuser, Markus Metzler, et al.
Expert Review of Clinical Pharmacology (2017) Vol. 11, Iss. 3, pp. 219-231
Closed Access | Times Cited: 49
Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement
Boguszewski MCS, CL Boguszewski, Wassim Chemaitilly, et al.
Yearbook of pediatric endocrinology (2022)
Open Access | Times Cited: 23
Childhood Cancer Treatments and Associated Endocrine Late Effects: A Concise Guide for the Pediatric Endocrinologist
Wassim Chemaitilly, Charles A. Sklar
Hormone Research in Paediatrics (2018) Vol. 91, Iss. 2, pp. 74-82
Closed Access | Times Cited: 40
Fertility considerations in targeted biologic therapy with tyrosine kinase inhibitors: a review
Anupama Rambhatla, Michael Strug, Jessica Garcia de Paredes, et al.
Journal of Assisted Reproduction and Genetics (2021) Vol. 38, Iss. 8, pp. 1897-1908
Open Access | Times Cited: 32
Oncofertility in Pediatric and Adolescent Patients
Rohini Chakravarthy, Monica M. Laronda, Sara Zarnegar‐Lumley
Advances in Oncology (2025)
Closed Access
Management of children and adolescents with chronic myeloid leukemia in chronic phase: International pediatric chronic myeloid leukemia expert panel recommendations
Frédéric Millot, Μirella Αmpatzidou, Nirmalya Roy Moulik, et al.
Leukemia (2025)
Closed Access
Management of Chronic Myeloid Leukemia in Children and Young Adults
Maegan Ford, Michael J. Mauro, Catherine Aftandilian, et al.
Current Hematologic Malignancy Reports (2022) Vol. 17, Iss. 5, pp. 121-126
Open Access | Times Cited: 18
Therapeutic drug monitoring of imatinib – how far are we in the leukemia setting?
Annie Rasmussen, Christen Lykkegaard Andersen, Allan Weimann, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 3, pp. 225-234
Closed Access | Times Cited: 3
Pharmacokinetics of Nilotinib in Pediatric Patients with Philadelphia Chromosome–Positive Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia
Nobuko Hijiya, C. Michel Zwaan, Carmelo Rizzari, et al.
Clinical Cancer Research (2019) Vol. 26, Iss. 4, pp. 812-820
Open Access | Times Cited: 27
Experience with ponatinib in paediatric patients with leukaemia
Jenna Rossoff, Van Huynh, Rachel E. Rau, et al.
British Journal of Haematology (2020) Vol. 189, Iss. 2, pp. 363-368
Open Access | Times Cited: 26
Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis
Monika Sparber‐Sauer, Daniel Orbach, Fariba Navid, et al.
British Journal of Cancer (2021) Vol. 124, Iss. 10, pp. 1637-1646
Open Access | Times Cited: 23
A phase 2 study of nilotinib in pediatric patients with CML: long-term update on growth retardation and safety
Nobuko Hijiya, Alexey Maschan, Carmelo Rizzari, et al.
Blood Advances (2021) Vol. 5, Iss. 14, pp. 2925-2934
Open Access | Times Cited: 18
BCR/ABL-Positive Chronic Myeloid Leukemia in Children: Current Treatment Approach
Jenna M. Menger, Ryan S. Sathianathen, Kathleen M. Sakamoto, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 3, pp. 250-257
Closed Access | Times Cited: 2
Treatment‐Free Remissions in Children With Chronic Myeloid Leukemia (CML): A Prospective Study From the Tata Memorial Hospital (TMH) Pediatric CML (pCML) Cohort
Nirmalya Roy Moulik, Swaminathan Keerthivasagam, Gaurav Chatterjee, et al.
American Journal of Hematology (2024)
Open Access | Times Cited: 2
Pharmacology of tyrosine kinase inhibitors in chronic myeloid leukemia; a clinician’s perspective
Deepam Pushpam, Sameer Bakhshi
DARU Journal of Pharmaceutical Sciences (2020) Vol. 28, Iss. 1, pp. 371-385
Open Access | Times Cited: 17
Risk Factors for Small Adult Height in Childhood Cancer Survivors
Charlotte Demoor‐Goldschmidt, Rodrigue S. Allodji, Neige Journy, et al.
Journal of Clinical Oncology (2020) Vol. 38, Iss. 16, pp. 1785-1796
Closed Access | Times Cited: 17
Pediatric Autologous Hematopoietic Stem Cell Transplantation: Safety, Efficacy, and Patient Outcomes. Literature Review
Anna Maria Testi, Maria Luisa Moleti, Alessia Angi, et al.
Pediatric Health Medicine and Therapeutics (2023) Vol. Volume 14, pp. 197-215
Open Access | Times Cited: 6
Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921
Erica Brivio, Edoardo Pennesi, Marieke E. Willemse, et al.
Journal of Clinical Oncology (2023) Vol. 42, Iss. 7, pp. 821-831
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top